According to Latest Research Study, the global market for mRNA Drug should grow from US$ million in 2024 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

China mRNA Drug market should grow from US$ million in 2024 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

The United States mRNA Drug market should grow from US$ million in 2024 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

In terms of type, Preventive Vaccines segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Hospital has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.

The global key manufacturers of mRNA Drug include Moderna, Pfizer, Zydus Cadila, Fosun Pharma, CureVAC, Sri Lankan Microorganisms, BioNtech, AstraZeneca and Janssen, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.

Messenger RNA (mRNA) is a single-stranded long ribonucleic acid that can transmit genetic information in DNA and synthesize proteins through translation. After mRNA enters the body, specific proteins can be expressed by autologous cells, avoiding the influence of in vitro factors; it can regulate the human immune system through endogenous expression of functional proteins, and eliminate autologous threats including cancer cells. The mRNA vaccine encoding the antigenic sequence is introduced into cells through a delivery platform such as lipid nanocarriers, and then human cells produce antigens through translation to activate the immune response.

This report aims to provide a comprehensive study of the global market for mRNA Drug.
Report Highlights:

(1) Global mRNA Drug market size (sales volume & revenue), history data from 2019-2023 and forecast data from 2024 to 2030.

(2) Global mRNA Drug market competitive situation, sales, revenue, price and market share, from 2019 to 2024.

(3) China mRNA Drug market competitive situation, sales, revenue, price and market share, from 2019 to 2024.

(4) Global mRNA Drug segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global mRNA Drug segment by type and by application and regional segment by type and by application.

(6) Global major production regions of mRNA Drug, capacity, production and trends.

(7) mRNA Drug industry supply chain, upstream, midstream and downstream analysis.

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Market segment by type, covers

Preventive Vaccines

Therapeutic Vaccine

Therapeutic Drugs

Market segment by application, can be divided into

Hospital

Clinic

Market segment by players, this report covers

Moderna

Pfizer

Zydus Cadila

Fosun Pharma

CureVAC

Sri Lankan Microorganisms

BioNtech

AstraZeneca

Janssen

1 Market Overview

1.1 mRNA Drug Definition

1.2 Global mRNA Drug Market Size and Forecast

1.2.1 By Revenue, Global mRNA Drug Market Size, 2019-2030

1.2.2 By Sales Volume, Global mRNA Drug Market Size, 2019-2030

1.2.3 Global mRNA Drug Price Trend, 2019-2030

1.3 China mRNA Drug Market Size and Forecast

1.3.1 By Revenue, China mRNA Drug Market Size, 2019-2030

1.3.2 By Sales Volume, China mRNA Drug Market Size, 2019-2030

1.3.3 China mRNA Drug Price Trend, 2019-2030

1.4 China Percentage in Global Market

1.4.1 By Revenue, China mRNA Drug Share in Global Market, 2019-2030

1.4.2 By Sales Volume, China mRNA Drug Share in Global Market, 2019-2030

1.4.3 mRNA Drug Market Size: China VS Global, 2019-2030

1.5 mRNA Drug Market Dynamics

1.5.1 mRNA Drug Market Drivers

1.5.2 mRNA Drug Market Restraints

1.5.3 mRNA Drug Industry Trends

1.5.4 mRNA Drug Industry Policy

2 Global Competitive Landscape by Company

2.1 Global mRNA Drug Revenue by Company, 2019-2024

2.2 Global mRNA Drug Sales Volume by Company, 2019-2024

2.3 Global mRNA Drug Price by Company, 2019-2024

2.4 Global mRNA Drug Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.5 Global mRNA Drug Concentration Ratio

2.6 Global mRNA Drug Mergers & Acquisitions, Expansion Plans

2.7 Global mRNA Drug Manufacturers Product Type

3 China Competitive Landscape by Company

3.1 China mRNA Drug Revenue by Company, 2019-2024

3.2 China mRNA Drug Sales Volume by Company, 2019-2024

3.3 China mRNA Drug mRNA Drug Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.4 China mRNA Drug Market, Sales Percentage of Local Players VS Foreign Players (2019-2024)

3.5 Chinese Local Players, mRNA Drug Domestic VS Export

3.6 China Market, mRNA Drug Import & Export

3.6.1 China Market, mRNA Drug Import & Export, 2019-2030

3.6.2 China mRNA Drug Import & Export Trends

3.6.3 Main Sources of China mRNA Drug Import

3.6.4 Export Destination of China mRNA Drug

4 mRNA Drug Production by Region

4.1 Global mRNA Drug Capacity, Production and Capacity Utilization, 2019-2030

4.2 Global Geographic Distribution of mRNA Drug Manufacturers

4.3 Global Major Manufacturers, mRNA Drug Capacity Expansion and Future Plans

4.4 Global mRNA Drug Capacity by Region

4.5 Global mRNA Drug Production by Region

4.5.1 Global mRNA Drug Production & Forecast by Region, 2019 VS 2024 VS 2030

4.5.2 Global mRNA Drug Production by Region, 2019-2024

4.5.3 Global mRNA Drug Production Market Share & Forecast by Region, 2019-2030

5 Industry Chain Analysis

5.1 mRNA Drug Industry Chain

5.2 mRNA Drug Upstream Analysis

5.2.1 mRNA Drug Core Raw Materials

5.2.2 Main Manufacturers of mRNA Drug Core Raw Materials

5.3 Midstream Analysis

5.4 Downstream Analysis

5.5 mRNA Drug Production Mode

5.6 mRNA Drug Procurement Model

5.7 mRNA Drug Industry Sales Model and Sales Channels

5.7.1 mRNA Drug Sales Model

5.7.2 mRNA Drug Typical Distributors

6 Sights by Type

6.1 mRNA Drug Classification

6.1.1 Preventive Vaccines

6.1.2 Therapeutic Vaccine

6.1.3 Therapeutic Drugs

6.2 By Type, Global mRNA Drug Market Size & CAGR, 2019 VS 2024 VS 2030

6.3 By Type, Global mRNA Drug Revenue, 2019-2030

6.4 By Type, Global mRNA Drug Sales Volume, 2019-2030

6.5 By Type, Global mRNA Drug Price, 2019-2030

7 Sights by Application

7.1 mRNA Drug Segment by Application

7.1.1 Hospital

7.1.2 Clinic

7.2 By Application, Global mRNA Drug Market Size & CAGR, 2019 VS 2024 VS 2030

7.3 By Application, Global mRNA Drug Revenue, 2019-2030

7.4 By Application, Global mRNA Drug Sales Volume, 2019-2030

7.5 By Application, Global mRNA Drug Price, 2019-2030

8 Sales Sights by Region

8.1 By Region, Global mRNA Drug Market Size, 2019 VS 2024 VS 2030

8.2 By Region, Global mRNA Drug Revenue, 2019-2030

8.3 By Region, Global mRNA Drug Sales Volume, 2019-2030

8.4 North America

8.4.1 North America mRNA Drug Market Size & Forecasts, 2019-2030

8.4.2 By Country, North America mRNA Drug Market Size Market Share

8.5 Europe

8.5.1 Europe mRNA Drug Market Size & Forecasts, 2019-2030

8.5.2 By Country, Europe mRNA Drug Market Size Market Share

8.6 Asia Pacific

8.6.1 Asia Pacific mRNA Drug Market Size & Forecasts, 2019-2030

8.6.2 By Country/Region, Asia Pacific mRNA Drug Market Size Market Share

8.7 South America

8.7.1 South America mRNA Drug Market Size & Forecasts, 2019-2030

8.7.2 By Country, South America mRNA Drug Market Size Market Share

8.8 Middle East & Africa

9 Sales Sights by Country Level

9.1 By Country, Global mRNA Drug Market Size & CAGR，2019 VS 2024 VS 2030

9.2 By Country, Global mRNA Drug Revenue, 2019-2030

9.3 By Country, Global mRNA Drug Sales Volume, 2019-2030

9.4 U.S.

9.4.1 U.S. mRNA Drug Market Size, 2019-2030

9.4.2 By Company, U.S. mRNA Drug Sales Volume Market Share, 2024

9.4.3 By Type, U.S. mRNA Drug Market Size, Share, 2024 VS 2030

9.4.4 By Application, U.S. mRNA Drug Market Size, Share, 2024 VS 2030

9.5 Europe

9.5.1 Europe mRNA Drug Market Size, 2019-2030

9.5.2 By Company, Europe mRNA Drug Sales Volume Market Share, 2024

9.5.3 By Type, Europe mRNA Drug Market Size, Share, 2024 VS 2030

9.5.4 By Application, Europe mRNA Drug Market Size, Share, 2024 VS 2030

9.6 China

9.6.1 China mRNA Drug Market Size, 2019-2030

9.6.2 By Company, China mRNA Drug Sales Volume Market Share, 2024

9.6.3 By Type, China mRNA Drug Market Size, Share, 2024 VS 2030

9.6.4 By Application, China mRNA Drug Market Size, Share, 2024 VS 2030

9.7 Japan

9.7.1 Japan mRNA Drug Market Size, 2019-2030

9.7.2 By Company, Japan mRNA Drug Sales Volume Market Share, 2024

9.7.3 By Type, Japan mRNA Drug Market Size, Share, 2024 VS 2030

9.7.4 By Application, Japan mRNA Drug Market Size, Share, 2024 VS 2030

9.8 South Korea

9.8.1 South Korea mRNA Drug Market Size, 2019-2030

9.8.2 By Company, South Korea mRNA Drug Sales Volume Market Share, 2024

9.8.3 By Type, South Korea mRNA Drug Market Size, Share, 2024 VS 2030

9.8.4 By Application, South Korea mRNA Drug Market Size, Share, 2024 VS 2030

9.9 Southeast Asia

9.9.1 Southeast Asia mRNA Drug Market Size, 2019-2030

9.9.2 By Company, Southeast Asia mRNA Drug Sales Volume Market Share, 2024

9.9.3 By Type, Southeast Asia mRNA Drug Market Size, Share, 2024 VS 2030

9.9.4 By Application, Southeast Asia mRNA Drug Market Size, Share, 2024 VS 2030

9.10 India

9.10.1 India mRNA Drug Market Size, 2019-2030

9.10.2 By Company, India mRNA Drug Sales Volume Market Share, 2024

9.10.3 By Type, India mRNA Drug Market Size, Share, 2024 VS 2030

9.10.4 By Application, India mRNA Drug Market Size, Share, 2024 VS 2030

9.11 Middle East & Asia

9.11.1 Middle East & Asia mRNA Drug Market Size, 2019-2030

9.11.2 By Company, Middle East & Asia mRNA Drug Sales Volume Market Share, 2024

9.11.3 By Type, Middle East & Asia mRNA Drug Market Size, Share, 2024 VS 2030

9.11.4 By Application, Middle East & Asia mRNA Drug Market Size, Share, 2024 VS 2030

10 Manufacturers Profile

10.1 Moderna

10.1.1 Moderna Company Information, Head Office, Market Area and Industry Position

10.1.2 Moderna mRNA Drug Models, Specifications and Application

10.1.3 Moderna mRNA Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.1.4 Moderna Company Profile and Main Business

10.1.5 Moderna Recent Developments

10.2 Pfizer

10.2.1 Pfizer Company Information, Head Office, Market Area and Industry Position

10.2.2 Pfizer mRNA Drug Models, Specifications and Application

10.2.3 Pfizer mRNA Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.2.4 Pfizer Company Profile and Main Business

10.2.5 Pfizer Recent Developments

10.3 Zydus Cadila

10.3.1 Zydus Cadila Company Information, Head Office, Market Area and Industry Position

10.3.2 Zydus Cadila mRNA Drug Models, Specifications and Application

10.3.3 Zydus Cadila mRNA Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.3.4 Zydus Cadila Company Profile and Main Business

10.3.5 Zydus Cadila Recent Developments

10.4 Fosun Pharma

10.4.1 Fosun Pharma Company Information, Head Office, Market Area and Industry Position

10.4.2 Fosun Pharma mRNA Drug Models, Specifications and Application

10.4.3 Fosun Pharma mRNA Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.4.4 Fosun Pharma Company Profile and Main Business

10.4.5 Fosun Pharma Recent Developments

10.5 CureVAC

10.5.1 CureVAC Company Information, Head Office, Market Area and Industry Position

10.5.2 CureVAC mRNA Drug Models, Specifications and Application

10.5.3 CureVAC mRNA Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.5.4 CureVAC Company Profile and Main Business

10.5.5 CureVAC Recent Developments

10.6 Sri Lankan Microorganisms

10.6.1 Sri Lankan Microorganisms Company Information, Head Office, Market Area and Industry Position

10.6.2 Sri Lankan Microorganisms mRNA Drug Models, Specifications and Application

10.6.3 Sri Lankan Microorganisms mRNA Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.6.4 Sri Lankan Microorganisms Company Profile and Main Business

10.6.5 Sri Lankan Microorganisms Recent Developments

10.7 BioNtech

10.7.1 BioNtech Company Information, Head Office, Market Area and Industry Position

10.7.2 BioNtech mRNA Drug Models, Specifications and Application

10.7.3 BioNtech mRNA Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.7.4 BioNtech Company Profile and Main Business

10.7.5 BioNtech Recent Developments

10.8 AstraZeneca

10.8.1 AstraZeneca Company Information, Head Office, Market Area and Industry Position

10.8.2 AstraZeneca mRNA Drug Models, Specifications and Application

10.8.3 AstraZeneca mRNA Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.8.4 AstraZeneca Company Profile and Main Business

10.8.5 AstraZeneca Recent Developments

10.9 Janssen

10.9.1 Janssen Company Information, Head Office, Market Area and Industry Position

10.9.2 Janssen mRNA Drug Models, Specifications and Application

10.9.3 Janssen mRNA Drug Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.9.4 Janssen Company Profile and Main Business

10.9.5 Janssen Recent Developments

11 Conclusion

12 Appendix

12.1 Research Methodology

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Market Estimation Model

12.4 Disclaimer

Table 1. mRNA Drug Market Size & CAGR: China VS Global, 2019-2030, US$ Million

Table 2. mRNA Drug Market Restraints

Table 3. mRNA Drug Market Trends

Table 4. mRNA Drug Industry Policy

Table 5. Global mRNA Drug Revenue by Company, 2019-2024, US$ million

Table 6. Global mRNA Drug Revenue Market Share by Company, 2019-2024

Table 7. Global mRNA Drug Sales Volume by Company, 2019-2024, (K Units)

Table 8. Global mRNA Drug Sales Volume Market Share by Company, 2019-2024

Table 9. Global mRNA Drug Price by Company, 2019-2024, (US$/Unit)

Table 10. Global mRNA Drug Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global mRNA Drug Mergers & Acquisitions, Expansion Plans

Table 12. Global mRNA Drug Manufacturers Product Type

Table 13. China mRNA Drug Revenue by Company, 2019-2024, US$ million

Table 14. China mRNA Drug Revenue Market Share by Company, 2019-2024

Table 15. China mRNA Drug Sales Volume by Company, 2019-2024, (K Units)

Table 16. China mRNA Drug Sales Volume Market Share by Company, 2019-2024

Table 17. China Market, mRNA Drug Production, Sales, Import and Export, 2019-2030, (K Units)

Table 18. China mRNA Drug Import & Export Trends

Table 19. Main Sources of China mRNA Drug Import

Table 20. Export Destination of China mRNA Drug

Table 21. Global Headquarters and Manufacturing Base of mRNA Drug Manufacturers

Table 22. Global Major Manufacturers, mRNA Drug Capacity Expansion and Future Plans

Table 23. Global mRNA Drug Production & Forecast by Region, 2019 VS 2024 VS 2030, (K Units)

Table 24. Global mRNA Drug Production by Region, 2019-2024, (K Units)

Table 25. Global mRNA Drug Production Forecast by Region, 2024-2030, (K Units)

Table 26. Global Key Players of mRNA Drug Upstream (Raw Materials)

Table 27. Global mRNA Drug Typical Customers

Table 28. mRNA Drug Typical Distributors

Table 29. By Type, Global mRNA Drug Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 30. By Application, Global mRNA Drug Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 31. By Region, Global mRNA Drug Market Size, 2019 VS 2024 VS 2030, US$ Million

Table 32. By Region, Global mRNA Drug Revenue, 2019-2030, US$ Million

Table 33. By Region, Global mRNA Drug Sales Volume, 2019-2030, (K Units)

Table 34. By Country, Global mRNA Drug Revenue & CAGR，2019 VS 2024 VS 2030, US$ Million

Table 35. By Country, Global mRNA Drug Revenue, 2019-2030, US$ Million

Table 36. By Country, Global mRNA Drug Revenue Market Share, 2019-2030

Table 37. By Country, Global mRNA Drug Sales Volume, 2019-2030, (K Units)

Table 38. By Country, Global mRNA Drug Sales Volume Market Share, 2019-2030

Table 39. Moderna Company Information, Head Office, Market Area and Industry Position

Table 40. Moderna mRNA Drug Models, Specifications and Application

Table 41. Moderna mRNA Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 42. Moderna Company Profile and Main Business

Table 43. Moderna Recent Developments

Table 44. Pfizer Company Information, Head Office, Market Area and Industry Position

Table 45. Pfizer mRNA Drug Models, Specifications and Application

Table 46. Pfizer mRNA Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 47. Pfizer Company Profile and Main Business

Table 48. Pfizer Recent Developments

Table 49. Zydus Cadila Company Information, Head Office, Market Area and Industry Position

Table 50. Zydus Cadila mRNA Drug Models, Specifications and Application

Table 51. Zydus Cadila mRNA Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 52. Zydus Cadila Company Profile and Main Business

Table 53. Zydus Cadila Recent Developments

Table 54. Fosun Pharma Company Information, Head Office, Market Area and Industry Position

Table 55. Fosun Pharma mRNA Drug Models, Specifications and Application

Table 56. Fosun Pharma mRNA Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 57. Fosun Pharma Company Profile and Main Business

Table 58. Fosun Pharma Recent Developments

Table 59. CureVAC Company Information, Head Office, Market Area and Industry Position

Table 60. CureVAC mRNA Drug Models, Specifications and Application

Table 61. CureVAC mRNA Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 62. CureVAC Company Profile and Main Business

Table 63. CureVAC Recent Developments

Table 64. Sri Lankan Microorganisms Company Information, Head Office, Market Area and Industry Position

Table 65. Sri Lankan Microorganisms mRNA Drug Models, Specifications and Application

Table 66. Sri Lankan Microorganisms mRNA Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 67. Sri Lankan Microorganisms Company Profile and Main Business

Table 68. Sri Lankan Microorganisms Recent Developments

Table 69. BioNtech Company Information, Head Office, Market Area and Industry Position

Table 70. BioNtech mRNA Drug Models, Specifications and Application

Table 71. BioNtech mRNA Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 72. BioNtech Company Profile and Main Business

Table 73. BioNtech Recent Developments

Table 74. AstraZeneca Company Information, Head Office, Market Area and Industry Position

Table 75. AstraZeneca mRNA Drug Models, Specifications and Application

Table 76. AstraZeneca mRNA Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 77. AstraZeneca Company Profile and Main Business

Table 78. AstraZeneca Recent Developments

Table 79. Janssen Company Information, Head Office, Market Area and Industry Position

Table 80. Janssen mRNA Drug Models, Specifications and Application

Table 81. Janssen mRNA Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 82. Janssen Company Profile and Main Business

Table 83. Janssen Recent Developments

List of Figure

Figure 1. mRNA Drug Picture

Figure 2. By Revenue, Global mRNA Drug Market Size and Forecast, 2019-2030, US$ Million

Figure 3. By Sales Volume, Global mRNA Drug Market Size and Forecast, 2019-2030, (K Units)

Figure 4. Global mRNA Drug Price Trend, 2019-2030, (US$/Unit)

Figure 5. By Revenue, China mRNA Drug Market Size and Forecast, 2019-2030, US$ million

Figure 6. By Sales Volume, China mRNA Drug Market Size and Forecast, 2019-2030, (K Units)

Figure 7. China mRNA Drug Price Trend, 2019-2030 (US$/Unit)

Figure 8. By Revenue, China mRNA Drug Share of Global Market, 2019-2030

Figure 9. By Sales Volume, China mRNA Drug Share of Global Market, 2019-2030

Figure 10. Global mRNA Drug Key Participants, Market Share, 2021 VS 2024 VS 2023

Figure 11. Global mRNA Drug Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2024

Figure 12. China mRNA Drug Key Participants, Market Share, 2021 VS 2024 VS 2023

Figure 13. China mRNA Drug Key Participants, Market Share, 2021 VS 2024 VS 2023

Figure 14. China mRNA Drug Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2019-2024

Figure 15. Chinese Local Players, Proportion of mRNA Drug Domestic VS Export, 2024

Figure 16. Global mRNA Drug Capacity, Production and Capacity Utilization, 2019-2030

Figure 17. Global mRNA Drug Capacity Market Share by Region, 2024 VS 2030

Figure 18. Global mRNA Drug Production Market Share & Forecast by Region, 2019-2030

Figure 19. mRNA Drug Industry Chain

Figure 20. mRNA Drug Procurement Model

Figure 21. mRNA Drug Sales Model

Figure 22. mRNA Drug Sales Channels, Direct Sales and Distribution

Figure 23. Preventive Vaccines

Figure 24. Therapeutic Vaccine

Figure 25. Therapeutic Drugs

Figure 26. By Type, Global mRNA Drug Revenue, 2019-2030, US$ Million

Figure 27. By Type, Global mRNA Drug Revenue Market Share, 2019-2030

Figure 28. By Type, Global mRNA Drug Sales Volume, 2019-2030, (K Units)

Figure 29. By Type, Global mRNA Drug Sales Volume Market Share, 2019-2030

Figure 30. By Type, Global mRNA Drug Price, 2019-2030, (US$/Unit)

Figure 31. Hospital

Figure 32. Clinic

Figure 33. By Application, Global mRNA Drug Revenue, 2019-2030, US$ Million

Figure 34. By Application, Global mRNA Drug Revenue Market Share, 2019-2030

Figure 35. By Application, Global mRNA Drug Sales Volume, 2019-2030, (K Units)

Figure 36. By Application, Global mRNA Drug Sales Volume Market Share, 2019-2030

Figure 37. By Application, Global mRNA Drug Price, 2019-2030, (US$/Unit)

Figure 38. By Region, Global mRNA Drug Revenue Market Share, 2019-2030

Figure 39. By Region, Global mRNA Drug Sales Volume Market Share, 2019-2030

Figure 40. North America mRNA Drug Revenue & Forecasts, 2019-2030, US$ Million

Figure 41. By Country, North America mRNA Drug Revenue Market Share, 2024

Figure 42. Europe mRNA Drug Revenue & Forecasts, 2019-2030, US$ Million

Figure 43. By Country, Europe mRNA Drug Revenue Market Share, 2024

Figure 44. Asia Pacific mRNA Drug Revenue & Forecasts, 2019-2030, US$ Million

Figure 45. By Country/Region, Asia Pacific mRNA Drug Revenue Market Share, 2024

Figure 46. South America mRNA Drug Revenue & Forecasts, 2019-2030, US$ Million

Figure 47. By Country, South America mRNA Drug Revenue Market Share, 2024

Figure 48. Middle East & Africa mRNA Drug Revenue & Forecasts, 2019-2030, US$ Million

Figure 49. U.S. mRNA Drug Sales Volume, 2019-2030, (K Units)

Figure 50. By Company, U.S. mRNA Drug Market Share, 2024

Figure 51. By Type, U.S. mRNA Drug Sales Volume Market Share, 2024 VS 2030

Figure 52. By Application, U.S. mRNA Drug Sales Volume Market Share, 2024 VS 2030

Figure 53. Europe mRNA Drug Sales Volume, 2019-2030, (K Units)

Figure 54. By Company, Europe mRNA Drug Market Share, 2024

Figure 55. By Type, Europe mRNA Drug Sales Volume Market Share, 2024 VS 2030

Figure 56. By Application, Europe mRNA Drug Sales Volume Market Share, 2024 VS 2030

Figure 57. China mRNA Drug Sales Volume, 2019-2030, (K Units)

Figure 58. By Company, China mRNA Drug Market Share, 2024

Figure 59. By Type, China mRNA Drug Sales Volume Market Share, 2024 VS 2030

Figure 60. By Application, China mRNA Drug Sales Volume Market Share, 2024 VS 2030

Figure 61. Japan mRNA Drug Sales Volume, 2019-2030, (K Units)

Figure 62. By Company, Japan mRNA Drug Market Share, 2024

Figure 63. By Type, Japan mRNA Drug Sales Volume Market Share, 2024 VS 2030

Figure 64. By Application, Japan mRNA Drug Sales Volume Market Share, 2024 VS 2030

Figure 65. South Korea mRNA Drug Sales Volume, 2019-2030, (K Units)

Figure 66. By Company, South Korea mRNA Drug Market Share, 2024

Figure 67. By Type, South Korea mRNA Drug Sales Volume Market Share, 2024 VS 2030

Figure 68. By Application, South Korea mRNA Drug Sales Volume Market Share, 2024 VS 2030

Figure 69. Southeast Asia mRNA Drug Sales Volume, 2019-2030, (K Units)

Figure 70. By Company, Southeast Asia mRNA Drug Market Share, 2024

Figure 71. By Type, Southeast Asia mRNA Drug Sales Volume Market Share, 2024 VS 2030

Figure 72. By Application, Southeast Asia mRNA Drug Sales Volume Market Share, 2024 VS 2030

Figure 73. India mRNA Drug Sales Volume, 2019-2030, (K Units)

Figure 74. By Company, India mRNA Drug Market Share, 2024

Figure 75. By Type, India mRNA Drug Sales Volume Market Share, 2024 VS 2030

Figure 76. By Application, India mRNA Drug Sales Volume Market Share, 2024 VS 2030

Figure 77. Middle East & Asia mRNA Drug Sales Volume, 2019-2030, (K Units)

Figure 78. By Company, Middle East & Asia mRNA Drug Market Share, 2024

Figure 79. By Type, Middle East & Asia mRNA Drug Sales Volume Market Share, 2024 VS 2030

Figure 80. By Application, Middle East & Asia mRNA Drug Sales Volume Market Share, 2024 VS 2030

Figure 81. Research Methodology

Figure 82. Breakdown of Primary Interviews

Figure 83. Bottom-up Approaches

Figure 84. Top-down Approaches

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)